Emerging Therapies for Huntington’s Disease – Focus on N-Terminal Huntingtin and Huntingtin Exon 1

Emerging Therapies for Huntington’s Disease – Focus on N-Terminal Huntingtin and Huntingtin Exon 1

M Leontien van der Bent, Melvin M Evers, Astrid Vallès uniQure biopharma B.V., Department of Research and Development, Amsterdam, the NetherlandsCorrespondence: Astrid Vallès, uniQure biopharma B.V, Postbus 22506, Amsterdam, 1100 DA, the Netherlands, Tel +31 20 240 6000, Email a.vallessanchez@uniqur...

Full description

Bibliographic Details
Main Authors: van der Bent ML, Evers MM, Vallès A
Format: Article
Language:English
Published: Dove Medical Press 2022-09-01
Series:Biologics: Targets & Therapy
Subjects:
huntingtin
n-terminal fragments
proteolysis
aberrant splicing
exon1 fragment
huntington’s disease therapeutics
Online Access:https://www.dovepress.com/emerging-therapies-for-huntingtons-disease--focus-on-n-terminal-huntin-peer-reviewed-fulltext-article-BTT

Internet

https://www.dovepress.com/emerging-therapies-for-huntingtons-disease--focus-on-n-terminal-huntin-peer-reviewed-fulltext-article-BTT

Similar Items